Charcot-Marie-Tooth Disease Type 2Y: Unraveling the Genetic Threads
Explore Charcot-Marie-Tooth Disease Type 2Y, a genetic condition affecting nerves, and the role of genetic testing in diagnosis, family planning, and treatment.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Charcot-Marie-Tooth Disease Type 4K: Unraveling Genetic Mysteries
Explore how genetic testing illuminates Charcot-Marie-Tooth disease type 4K, offering accurate diagnoses, personalized treatments, and crucial genetic counseling.
Chorea, Childhood-Onset, with Psychomotor Retardation: The Genetic Key to Unlocking Treatment Paths
Explore the impact of genetic testing on diagnosing childhood-onset chorea with psychomotor retardation, offering insights into personalized treatment strategies.
Cracking the Code: Understanding Combined Oxidative Phosphorylation Defect Type 27
Explore COXPD-27, a rare mitochondrial disorder. Learn how genetic testing aids in early diagnosis and personalized management, improving patient outcomes.
Cracking the Code: Understanding Combined Oxidative Phosphorylation Defect Type 30
Explore the role of genetic testing in diagnosing COXPD-30, a rare mitochondrial disorder, and discover personalized treatment strategies for improved outcomes.
Deciphering Combined Oxidative Phosphorylation Deficiency 28: A Genetic Testing Perspective
Explore the role of genetic testing in diagnosing and managing COXPD28, a rare mitochondrial disorder linked to VARS2 mutations, and improve patient care.
Understanding Combined Oxidative Phosphorylation Deficiency 29: The Role of Genetic Testing
Explore the impact of genetic testing on diagnosing COXPD29, a rare mitochondrial disorder, and how it leads to personalized treatment and informed family planning.
Confronting Complex Lethal Osteochondrodysplasia: The Role of Genetic Testing
Explore the crucial role of genetic testing in diagnosing complex lethal osteochondrodysplasia, aiding early detection, family planning, and potential treatment strategies.